Showing results (21-30 of 217) with videos related to
Sort By:
Pageof 22
Archives of Pathology & Laboratory Medicine|August 6, 2009
Variation of monosomy 3 status within uveal melanomaLynn Schoenfield, James Pettay, Raymond R Tubbs, et al.American Journal of Clinical Pathology|July 17, 2008
HER2 overexpression and amplification in urothelial carcinoma of the bladder is associated with MYC coamplification in a subset of casesDonna E Hansel, Eric Swain, Robert Dreicer, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|March 15, 2002
Tissue microarrays: a powerful tool for high-throughput analysis of clinical specimens: a review of the method with validation dataMarek Skacel, Brad Skilton, James D Pettay, et al.Frontiers in Bioscience : a Journal and Virtual Library|January 10, 2002
Interphase fluorescence in-situ hybridization in the diagnosis of bladder cancerMarek Skacel, Louis S Liou, James D Pettay, et al.American Journal of Clinical Pathology|July 31, 2013
Immunoarchitectural patterns of germinal center antigens including LMO2 assist in the differential diagnosis of marginal zone lymphoma vs follicular lymphomaKathryn S Dyhdalo, Christopher Lanigan, Raymond R Tubbs, et al.Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 29, 2007
Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 Status in adenocarcinoma of the breast: a single institution experienceRaymond R Tubbs, David G Hicks, James Cook, et al.American Journal of Clinical Pathology|January 23, 2008
HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic toolsDavid G Hicks, Swati KulkarniArchives of Pathology & Laboratory Medicine|June 4, 2008
Trastuzumab as adjuvant therapy for early breast cancer: the importance of accurate human epidermal growth factor receptor 2 testingDavid G Hicks, Swati KulkarniAnnals of Surgical Oncology|April 10, 2008
HER2-positive early breast cancer and trastuzumab: a surgeon's perspectiveSwati Kulkarni, David G HicksAmerican Journal of Clinical Pathology|May 17, 2011
Diagnostic yield of bone marrow and peripheral blood FISH panel testing in clinically suspected myelodysplastic syndromes and/or acute myeloid leukemia: a prospective analysis of 433 casesJoshua F Coleman, Karl S Theil, Raymond R Tubbs, et al.Pageof 22